Green Thumb Industries Inc. Short Interest Update

Green Thumb Industries Inc. (OTCMKTS:GTBIF - Get Free Report) experienced a notable reduction in short interest during February. As of February 28th, total short interest was reported at 12,700 shares, reflecting a decrease of 14.8% from the 14,900 shares recorded on February 13th. Currently, only 0.0% of the company's shares are short sold. With an average daily trading volume of 723,800 shares, the days-to-cover ratio stands at 0.0 days.

Green Thumb Industries Stock Performance

On Wednesday, GTBIF shares declined by $0.06, bringing the stock price to $6.21. The trading volume for the day was 211,195 shares, below its average volume of 474,065 shares. The company's market capitalization is approximately $1.32 billion, with a P/E ratio of 25.88 and a beta of 1.30. The stock has seen a fifty-two week low of $6.08 and a high of $16.33.

Green Thumb Industries announced its quarterly earnings on February 26th, reporting earnings per share of $0.04, which fell short of the expected $0.06 by $0.02. The reported revenue for the quarter was $294.32 million, slightly higher than the consensus estimate of $289.66 million. The company reported a net margin of 5.38% and a return on equity of 3.39%. Analysts predict that Green Thumb Industries will achieve earnings per share of 0.32 for the current year.

About Green Thumb Industries

Green Thumb Industries Inc. is involved in the manufacture, distribution, marketing, and sale of cannabis products for both medical and adult-use markets in the United States. The company operates through two main segments: Retail and Consumer Packaged Goods. Its product offerings include cannabis flower, processed items like pre-rolls, concentrates, vapes, capsules, tinctures, edibles, and topicals, marketed under various brands such as &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM.

Investment Considerations

Before deciding whether to invest in Green Thumb Industries, it is important to consider expert opinions. While the current consensus reports a Strong Buy rating for the stock, some top analysts may recommend alternative investments that could potentially offer better returns.

GreenThumb, Stocks, ShortInterest